Soligenix Inc
Biotechnology
Healthcare
SNGX
3.05 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.16
52 week high
4.96
high
2.18
52 week low
0.00
low
1.81
growth
-48.95 %
previous Close
2.33
P/E ratio
market cap
9.07 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
22.64 %
eps surprise
21.90 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top